Association of periprocedural intravenous morphine use on clinical outcomes in ST-elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention: Systematic review and meta-analysis.
William ChanDavid Hongwei LiuJason BloomSamer NoamanWilliam ChanPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
Periprocedural intravenous morphine administration was not associated with adverse short-term clinical outcomes in patients undergoing primary PCI for STEMI. Further randomized trial data are needed to evaluate the pharmacologic interaction between morphine and P2Y12 antagonists with clinical outcomes.
Keyphrases
- percutaneous coronary intervention
- st elevation myocardial infarction
- st segment elevation myocardial infarction
- acute myocardial infarction
- acute coronary syndrome
- coronary artery disease
- antiplatelet therapy
- coronary artery bypass grafting
- patients undergoing
- high dose
- coronary artery bypass
- atrial fibrillation
- heart failure
- newly diagnosed
- left ventricular
- venous thromboembolism
- artificial intelligence
- low dose
- catheter ablation